Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News ESC 2025

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

Todd Neale

September 03, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

Advertisement

HELP-MI SWEDEHEART: Routine H. Pylori Screening Doesn’t Lessen Bleeding After MI

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Experts Fear Coronary CT Advice for Patients Misses the Mark

New Advanced Training Outlined for Future Vascular Medicine Specialists

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Missed Opportunities: Many HF Patients Not Tested for CAD

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content